Matches in Wikidata for { <http://www.wikidata.org/entity/Q33422543> ?p ?o ?g. }
- Q33422543 description "2015 nî lūn-bûn" @default.
- Q33422543 description "2015 թուականի Մայիսին հրատարակուած գիտական յօդուած" @default.
- Q33422543 description "2015 թվականի մայիսին հրատարակված գիտական հոդված" @default.
- Q33422543 description "2015年の論文" @default.
- Q33422543 description "2015年論文" @default.
- Q33422543 description "2015年論文" @default.
- Q33422543 description "2015年論文" @default.
- Q33422543 description "2015年論文" @default.
- Q33422543 description "2015年論文" @default.
- Q33422543 description "2015年论文" @default.
- Q33422543 description "2015年论文" @default.
- Q33422543 description "2015年论文" @default.
- Q33422543 description "2015年论文" @default.
- Q33422543 description "2015年论文" @default.
- Q33422543 description "2015年论文" @default.
- Q33422543 description "2015년 논문" @default.
- Q33422543 description "article científic" @default.
- Q33422543 description "article scientific" @default.
- Q33422543 description "article scientifique (publié 2015)" @default.
- Q33422543 description "articol științific" @default.
- Q33422543 description "articolo scientifico" @default.
- Q33422543 description "artigo científico (publicado na 2015)" @default.
- Q33422543 description "artigo científico (publicado na 2015)" @default.
- Q33422543 description "artigo científico" @default.
- Q33422543 description "artikull shkencor" @default.
- Q33422543 description "artikulong pang-agham" @default.
- Q33422543 description "artykuł naukowy" @default.
- Q33422543 description "artículo científico publicado en 2015" @default.
- Q33422543 description "artículu científicu espublizáu en 2015" @default.
- Q33422543 description "bilimsel makale" @default.
- Q33422543 description "bài báo khoa học" @default.
- Q33422543 description "mokslinis straipsnis" @default.
- Q33422543 description "naučni članak" @default.
- Q33422543 description "scienca artikolo" @default.
- Q33422543 description "scientific article" @default.
- Q33422543 description "teaduslik artikkel" @default.
- Q33422543 description "tieteellinen artikkeli" @default.
- Q33422543 description "tudományos cikk" @default.
- Q33422543 description "vedecký článok" @default.
- Q33422543 description "vetenskaplig artikel" @default.
- Q33422543 description "videnskabelig artikel (udgivet 2015)" @default.
- Q33422543 description "vitenskapelig artikkel" @default.
- Q33422543 description "vitskapeleg artikkel" @default.
- Q33422543 description "vědecký článek" @default.
- Q33422543 description "wetenschappelijk artikel" @default.
- Q33422543 description "wissenschaftlicher Artikel" @default.
- Q33422543 description "επιστημονικό άρθρο" @default.
- Q33422543 description "мақолаи илмӣ" @default.
- Q33422543 description "мақолаи илмӣ" @default.
- Q33422543 description "наукова стаття, опублікована в травні 2015" @default.
- Q33422543 description "научна статия" @default.
- Q33422543 description "научная статья" @default.
- Q33422543 description "научни чланак" @default.
- Q33422543 description "научни чланак" @default.
- Q33422543 description "מאמר מדעי" @default.
- Q33422543 description "سائنسی مضمون" @default.
- Q33422543 description "مقالة علمية" @default.
- Q33422543 description "مقالهٔ علمی" @default.
- Q33422543 description "২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33422543 description "บทความทางวิทยาศาสตร์" @default.
- Q33422543 description "სამეცნიერო სტატია" @default.
- Q33422543 name "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 name "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 name "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 type Item @default.
- Q33422543 label "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 label "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 label "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 prefLabel "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 prefLabel "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 prefLabel "Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies" @default.
- Q33422543 P1433 Q33422543-CFDC27F0-D93E-449B-B0A2-7C2CAC14B3CF @default.
- Q33422543 P1476 Q33422543-705E1CB4-5AEB-4228-8367-DF7144E36E0E @default.
- Q33422543 P2093 Q33422543-35064B73-68EA-469A-9EF2-B4A301BA6CD3 @default.
- Q33422543 P2093 Q33422543-4960A957-BE62-4F00-BCA5-02F659A6C0EE @default.
- Q33422543 P2093 Q33422543-6449827F-7D76-4938-88B0-113D06ACB020 @default.
- Q33422543 P2093 Q33422543-778024D8-2A7F-42F2-A014-FF22272C0518 @default.
- Q33422543 P2093 Q33422543-819846AE-E697-4725-B234-D85DD873B2E5 @default.
- Q33422543 P2093 Q33422543-83A959A3-10E6-41AA-8C39-E29427083243 @default.
- Q33422543 P2093 Q33422543-A39AFB88-E7FC-450D-8490-F6DB2D80534F @default.
- Q33422543 P2093 Q33422543-DDFA0565-0659-408B-9CA1-968FCE121A69 @default.
- Q33422543 P2093 Q33422543-EEBE01C2-139F-458D-A5B7-0CEC67FC9496 @default.
- Q33422543 P2860 Q33422543-035492C6-1BF1-470F-A414-6A600CD735EB @default.
- Q33422543 P2860 Q33422543-0F16784C-9B11-4A3D-B7E2-18D316C8D15A @default.
- Q33422543 P2860 Q33422543-196A5186-5DD5-4704-A561-A9BA00E05B24 @default.
- Q33422543 P2860 Q33422543-1C2F0B72-6767-43A3-AC1B-DED0DCD4C333 @default.
- Q33422543 P2860 Q33422543-22D2A40F-473F-41B5-A8B2-A2F820813129 @default.
- Q33422543 P2860 Q33422543-2CFE10B7-C404-4A7A-B640-C297CC3DADF1 @default.
- Q33422543 P2860 Q33422543-38436575-F259-47A3-882D-961CA68AA3F6 @default.
- Q33422543 P2860 Q33422543-3D79E70D-8DB3-4F3A-A893-61A0488F3B81 @default.
- Q33422543 P2860 Q33422543-47461982-2086-454E-8999-06B8B1B86AA7 @default.
- Q33422543 P2860 Q33422543-4C74AC23-76B8-44DC-9BB3-4FA2ED6F883C @default.
- Q33422543 P2860 Q33422543-5248F03D-8C33-41C0-AD93-D61B161B21E0 @default.
- Q33422543 P2860 Q33422543-542C5EFD-A37D-467D-8ADA-A14C510AD113 @default.
- Q33422543 P2860 Q33422543-5AF45C37-6EFB-405F-96FC-E4AF4D719FF7 @default.
- Q33422543 P2860 Q33422543-5C0BC8FA-D51E-4ABB-9F37-E88CB40CF29F @default.
- Q33422543 P2860 Q33422543-7B5B998D-4CF2-4009-A6AA-DA1BB1E9EF48 @default.
- Q33422543 P2860 Q33422543-82F42FF0-21B8-4AC7-AFE0-EC025C9CBCC0 @default.
- Q33422543 P2860 Q33422543-8A5524B4-FAA1-402D-85B3-0E548A7C1A49 @default.
- Q33422543 P2860 Q33422543-8B823FAA-48AD-4F38-889E-B2945F3E1CD1 @default.